期刊文献+

肝、肾及肝肾联合移植患者围手术期血浆AT活性检测及其临床意义

The Detection and Clinical Significance of Antithromnin Activity in Patients Follows Liver Transplantation,Kidney Transplantation,Combined Liver-Kidney Transplantation
暂未订购
导出
摘要 目的探讨肝、肾及肝肾联合移植患者围手术期及恢复期血浆AT活性测定的动态变化及其临床意义。方法观察了176例各类终末期肝病患者、69例肾病患者、16例肝肾综合征患者在围手术期间血浆AT活性的动态变化。均于术前、术中、术后10d每天抽取静脉血,用发色底物法测定AT活性,并给予分析。结果3组患者术中、术后早期血浆AT活性降低,恢复期AT的活性逐渐升高;肾脏移植组AT活性的恢复最快,与其它两组有显著差异性,而肝移植组与肝肾联合移植组AT的恢复无显著差异性。结论AT活性的恢复是衡量移植物成功的较好指标之一;术后早期受者血液的抗凝作用减弱,处于危险的血栓形成高凝状态之中。 Objective To explore the detection of antithrombin activity (AT:A) in patients during surgery period and the recovery period to forecast after liver transplantation , kidney transplantation , combined liver- kidney transplantation. Methods observed alterations of AT- A in 176 cases of end- stage liver disease in liver transplant patients ,69 cases nehprotic syndrome, 16 cases hepatorenal syndrome during surgery period . All the samples were obtained at preoperative stage and every day after operation and analyzed by the substrate linked with color assay in CA7000. Results In contrast to preoperative stage AT:A gradually decreased before reperfusion and gradually increased in recovery period, In comparison to the other groups there was significant difference in kidney transplantation . AT:A did not display significant changes between liver transplantation and combined liver-kidney transplantation. Conclusion It is very important to measure AT : A in predicating the success of transplantation . anti- coagulant functions were deceased at the early stage. It indicated the risk of potential thrombosis.
出处 《血栓与止血学》 2009年第3期122-124,共3页 Chinese Journal of Thrombosis and Hemostasis
关键词 抗凝血酶 肝脏移植 肾脏移植 肝肾联合移植 Antithrombin activity Liver transplantation Kidney transplantation Combined liverkidney transplantation
  • 相关文献

参考文献8

  • 1BRINKHOUS K M, SMITH HP,WARNERE D,et al. The inhibition of blood clotting:anunidentified substance which acts in conjunction with heparin to prevent the conversion of prothrombin to thrombin [J]. Am J Physical. 1939,125:683-687.
  • 2MARCREITER R, KRAMER R, HUBER C et al Combined liver and kidney transplantation[ J]. Lancet 1984 1 : 1077-1078.
  • 3FONG TL, BUNNAPRADIST S, JORDAN SC, et al. Analysis of the united Network for Organ Sharing database comparing revel allografts and patient survival combined liver kidney transplantation with the contralateral allografts in kidney alone or kidney pancreas transplantation [ J ]. Transplantation, 2003, 76 (2) : 348- 353.
  • 4刘丽,穆红,肖萍.肝移植中血栓与止血指标变化分析[J].血栓与止血学,1999,6(2):63-65. 被引量:1
  • 5顾青,邱丽君,周少春,沈立松.尿毒症患者血栓前状态的探讨[J].血栓与止血学,2008,14(1):12-14. 被引量:8
  • 6宋丽洁,赵怡雯,姚桂玲,王海燕.肝移植患者围手术期血浆AT活性检测及其临床意义[J].血栓与止血学,2006,12(6):256-258. 被引量:3
  • 7赖添顺,郭振辉,孙杰,唐柚青,霍枫,苏磊.肝移植术后早期腹腔出血及其处理的探讨[J].血栓与止血学,2008,14(2):74-77. 被引量:1
  • 8刘泽霖,马西.抗凝药物与抗凝治疗[M]//刘泽霖,贺石林,李家增,血栓性疾病的诊断与治疗.北京:人民卫生出版社,2000:158-186.

二级参考文献20

  • 1宋丽洁,丁琪,姚桂玲,王海燕.抗凝血酶活性变化的研究及临床意义[J].血栓与止血学,2006,12(4):180-182. 被引量:14
  • 2[2]HATANO E,TERAJIMA H,YABE S,et al.Hepatic artery thrombosis in living related Liver transplantation[J].Transplantation,1997,64:.1443-1446.
  • 3[3]LANGNAS AN,MARUJO W,STRATTA RW,et al.Vascular complications after liver transplantation[J].Am J Surg,1991,23:76-82.
  • 4[4]BRINKHOUS K M,SMITH HP,WARNERE D,et al.The inhibition of blood clotting:anunidentified substance which acts in conjunction with heparin to prevent the conversion of prothrombin to thrombin[J].Am J Physical,1939,125:683-687.
  • 5[1]EBERST M E,BERKOWITZ L R.Hemostasis in renal disease:pathophysiology and management[J].Am J Med,1994,96:168-179.
  • 6[3]STENVINKEL P.Endothelial dysfunction and inflammation is there a link[J].Nephrol Dial Transplant,2001,16(10):1968-1971.
  • 7[4]BOSTOM AG,SHEMIN D,LAPANE KL,et al.Hyper-homocysteinemia and traditional cardiovascular disease risk factor in end stage renal disease patients on dialysis:a case-control study[J].Atheroscaerosis,1995,114(1):93-103.
  • 8[5]PERNA AF,INGROSSO D,GALLETTI P,et al.Membrane protein damage and methylation reactions in chronic renal failure[J].Kidney Int,1996,50(2):358-366.
  • 9[6]Bostom AG,Culleton BF.Hyperhomocysteinemia in chronic renal disease[J].J Am Soc Nephrol,1999,10(4):891-900.
  • 10[7]RAJANNA S,ICHIRO I,RAYMOND M.Uremic patients have decreased shrear-induced platelet aggregation mediated by decreased availability of glycoprotein Ⅱb-Ⅲa receptors[J].Am J Kidney Dis,1996,27:355-364.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部